MERGER ALERT - CIT, BBIO, and LSAC: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies
NEW YORK, NY / ACCESSWIRE / October 23, 2020 / The following statement is being issued by Levi & Korsinsky, LLP:
Levi & Korsinsky, LLP announces that investigations have commenced on behalf of shareholders of the following publicly-traded companies.
CIT Group Inc. (NYSE:CIT)
Agreement Announcement: October 16, 2020
Transaction Details: Under the terms of the merger, CIT Group stockholders will receive 0.0620 shares of First Citizens Class A common stock for each share of CIT Group common stock they own.
To learn more about the CIT action and your rights, go to:
BridgeBio Pharma, Inc. (NASDAQ:BBIO)
Agreement Announcement: October 5, 2020
Transaction Details: Under the terms of the merger, BridgeBio has agreed to acquire all of the outstanding common stock of Eidos it does not already own, representing approximately 36.3% of Eidos' outstanding shares. Eidos stockholders will have the right to receive in the transaction, at their election, either 1.85 shares of BridgeBio common stock or $73.26 in cash per Eidos share in the transaction.
To learn more about the BBIO investigation and your rights, go to:
LifeSci Acquisition Corp. (NASDAQ:LSAC)
Merger Announcement: September 29, 2020
Transaction Details: The terms of the merger, current stockholders of Vincera will own approximately 40% of the combined company.
To learn more about the LSAC investigation and your rights, go to:
Levi & Korsinsky is a nationally recognized firm with offices in New York, Connecticut, California, and Washington, D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits, and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Fax: (212) 363-7171
SOURCE: Levi & Korsinsky, LLP
View source version on accesswire.com: